Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

avapritinib 5 midostaurin 4 masitinib 2 Imatinib Mesylate 2 sarilumab 1 ripretinib 1 obatoclax 1 nilotinib 1 ibrutinib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 denileukin diftitox 1 auricularum 1 Thalidomide 1 Ranitidine 1 Phlebotomy 1 Interviews as Topic 1 Ibuprofen 1 Everolimus 1 Diphenhydramine 1 Dexamethasone 1 Denosumab 1 Dasatinib 1 Cladribine 1 Calcium Dobesilate 1 Brentuximab Vedotin 1 Azacitidine 1 Acetaminophen 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mastocytosis, Systemic × Denosumab × Myeloid × Clear all

NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡